Premature ventricular contraction other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 48: | Line 48: | ||
|bgcolor="LemonChiffon" |<nowiki></nowiki>'''1.''' In [[patients]] with [[ischemic cardiomyopathy]], [[Nonischemic cardiomyopathy|NICM]], or [[Congenital heart disease|adult congenital heart disease]] who have [[syncope]] or other [[Ventricular arrhythmia|VA]] [[symptoms]] and who do not meet indications for a [[primary prevention]] [[Implantable cardioverter defibrillator|ICD]], an [[Electrophysiologic Testing|electrophysiological study]] can be useful for assessing the risk of [[sustained VT]] ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]]).''<ref name="BuxtonLee2000">{{cite journal|last1=Buxton|first1=Alfred E.|last2=Lee|first2=Kerry L.|last3=DiCarlo|first3=Lorenzo|last4=Gold|first4=Michael R.|last5=Greer|first5=G. Stephen|last6=Prystowsky|first6=Eric N.|last7=O'Toole|first7=Michael F.|last8=Tang|first8=Anthony|last9=Fisher|first9=John D.|last10=Coromilas|first10=James|last11=Talajic|first11=Mario|last12=Hafley|first12=Gail|title=Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death|journal=New England Journal of Medicine|volume=342|issue=26|year=2000|pages=1937–1945|issn=0028-4793|doi=10.1056/NEJM200006293422602}}</ref><ref name="BuxtonLee2002">{{cite journal|last1=Buxton|first1=Alfred E.|last2=Lee|first2=Kerry L.|last3=Hafley|first3=Gail E.|last4=Wyse|first4=D. George|last5=Fisher|first5=John D.|last6=Lehmann|first6=Michael H.|last7=Pires|first7=Luis A.|last8=Gold|first8=Michael R.|last9=Packer|first9=Douglas L.|last10=Josephson|first10=Mark E.|last11=Prystowsky|first11=Eric N.|last12=Talajic|first12=Mario R.|title=Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease|journal=Circulation|volume=106|issue=19|year=2002|pages=2466–2472|issn=0009-7322|doi=10.1161/01.CIR.0000037224.15873.83}}</ref><ref name="CostantiniHohnloser2009">{{cite journal|last1=Costantini|first1=Otto|last2=Hohnloser|first2=Stefan H.|last3=Kirk|first3=Malcolm M.|last4=Lerman|first4=Bruce B.|last5=Baker|first5=James H.|last6=Sethuraman|first6=Barathi|last7=Dettmer|first7=Mary M.|last8=Rosenbaum|first8=David S.|title=The ABCD (Alternans Before Cardioverter Defibrillator) Trial|journal=Journal of the American College of Cardiology|volume=53|issue=6|year=2009|pages=471–479|issn=07351097|doi=10.1016/j.jacc.2008.08.077}}</ref><ref name="BourkeRichards1991">{{cite journal|last1=Bourke|first1=John P.|last2=Richards|first2=David A.B.|last3=Ross|first3=David L.|last4=Wallace|first4=Elizabeth M.|last5=McGuire|first5=Mark A.|last6=Uther|first6=John B.|title=Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening|journal=Journal of the American College of Cardiology|volume=18|issue=3|year=1991|pages=780–788|issn=07351097|doi=10.1016/0735-1097(91)90802-G}}</ref><ref name="SchmittBarthel2001">{{cite journal|last1=Schmitt|first1=Claus|last2=Barthel|first2=Petra|last3=Ndrepepa|first3=Gjin|last4=Schreieck|first4=Jürgen|last5=Plewan|first5=Andreas|last6=Schömig|first6=A|last7=Schmidt|first7=Georg|title=Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers|journal=Journal of the American College of Cardiology|volume=37|issue=7|year=2001|pages=1901–1907|issn=07351097|doi=10.1016/S0735-1097(01)01246-3}}</ref><ref name="BaileyBerson2001">{{cite journal|last1=Bailey|first1=James J|last2=Berson|first2=Alan S|last3=Handelsman|first3=Harry|last4=Hodges|first4=Morrison|title=Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction|journal=Journal of the American College of Cardiology|volume=38|issue=7|year=2001|pages=1902–1911|issn=07351097|doi=10.1016/S0735-1097(01)01667-9}}</ref><ref name="Hilfiker2015">{{cite journal|last1=Hilfiker|first1=Gabriela|title=Utility of electrophysiological studies to predict arrhythmic events|journal=World Journal of Cardiology|volume=7|issue=6|year=2015|pages=344|issn=1949-8462|doi=10.4330/wjc.v7.i6.344}}</ref><nowiki/> | |bgcolor="LemonChiffon" |<nowiki></nowiki>'''1.''' In [[patients]] with [[ischemic cardiomyopathy]], [[Nonischemic cardiomyopathy|NICM]], or [[Congenital heart disease|adult congenital heart disease]] who have [[syncope]] or other [[Ventricular arrhythmia|VA]] [[symptoms]] and who do not meet indications for a [[primary prevention]] [[Implantable cardioverter defibrillator|ICD]], an [[Electrophysiologic Testing|electrophysiological study]] can be useful for assessing the risk of [[sustained VT]] ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]]).''<ref name="BuxtonLee2000">{{cite journal|last1=Buxton|first1=Alfred E.|last2=Lee|first2=Kerry L.|last3=DiCarlo|first3=Lorenzo|last4=Gold|first4=Michael R.|last5=Greer|first5=G. Stephen|last6=Prystowsky|first6=Eric N.|last7=O'Toole|first7=Michael F.|last8=Tang|first8=Anthony|last9=Fisher|first9=John D.|last10=Coromilas|first10=James|last11=Talajic|first11=Mario|last12=Hafley|first12=Gail|title=Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death|journal=New England Journal of Medicine|volume=342|issue=26|year=2000|pages=1937–1945|issn=0028-4793|doi=10.1056/NEJM200006293422602}}</ref><ref name="BuxtonLee2002">{{cite journal|last1=Buxton|first1=Alfred E.|last2=Lee|first2=Kerry L.|last3=Hafley|first3=Gail E.|last4=Wyse|first4=D. George|last5=Fisher|first5=John D.|last6=Lehmann|first6=Michael H.|last7=Pires|first7=Luis A.|last8=Gold|first8=Michael R.|last9=Packer|first9=Douglas L.|last10=Josephson|first10=Mark E.|last11=Prystowsky|first11=Eric N.|last12=Talajic|first12=Mario R.|title=Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease|journal=Circulation|volume=106|issue=19|year=2002|pages=2466–2472|issn=0009-7322|doi=10.1161/01.CIR.0000037224.15873.83}}</ref><ref name="CostantiniHohnloser2009">{{cite journal|last1=Costantini|first1=Otto|last2=Hohnloser|first2=Stefan H.|last3=Kirk|first3=Malcolm M.|last4=Lerman|first4=Bruce B.|last5=Baker|first5=James H.|last6=Sethuraman|first6=Barathi|last7=Dettmer|first7=Mary M.|last8=Rosenbaum|first8=David S.|title=The ABCD (Alternans Before Cardioverter Defibrillator) Trial|journal=Journal of the American College of Cardiology|volume=53|issue=6|year=2009|pages=471–479|issn=07351097|doi=10.1016/j.jacc.2008.08.077}}</ref><ref name="BourkeRichards1991">{{cite journal|last1=Bourke|first1=John P.|last2=Richards|first2=David A.B.|last3=Ross|first3=David L.|last4=Wallace|first4=Elizabeth M.|last5=McGuire|first5=Mark A.|last6=Uther|first6=John B.|title=Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening|journal=Journal of the American College of Cardiology|volume=18|issue=3|year=1991|pages=780–788|issn=07351097|doi=10.1016/0735-1097(91)90802-G}}</ref><ref name="SchmittBarthel2001">{{cite journal|last1=Schmitt|first1=Claus|last2=Barthel|first2=Petra|last3=Ndrepepa|first3=Gjin|last4=Schreieck|first4=Jürgen|last5=Plewan|first5=Andreas|last6=Schömig|first6=A|last7=Schmidt|first7=Georg|title=Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers|journal=Journal of the American College of Cardiology|volume=37|issue=7|year=2001|pages=1901–1907|issn=07351097|doi=10.1016/S0735-1097(01)01246-3}}</ref><ref name="BaileyBerson2001">{{cite journal|last1=Bailey|first1=James J|last2=Berson|first2=Alan S|last3=Handelsman|first3=Harry|last4=Hodges|first4=Morrison|title=Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction|journal=Journal of the American College of Cardiology|volume=38|issue=7|year=2001|pages=1902–1911|issn=07351097|doi=10.1016/S0735-1097(01)01667-9}}</ref><ref name="Hilfiker2015">{{cite journal|last1=Hilfiker|first1=Gabriela|title=Utility of electrophysiological studies to predict arrhythmic events|journal=World Journal of Cardiology|volume=7|issue=6|year=2015|pages=344|issn=1949-8462|doi=10.4330/wjc.v7.i6.344}}</ref><nowiki/> | ||
|- | |- | ||
|} | |||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightCoral"|[[ESC guidelines classification scheme#Classification of Recommendations|Class III]] | |||
|- | |||
|bgcolor="LightCoral" |<nowiki></nowiki> '''1.''' [[Aspirin]] is not recommended in [[children]] due to the associated risk of [[Reye's syndrome|Reye’s syndrome]] and [[hepatotoxicity]]. | |||
'''2.''' [[Corticosteroids]] are not recommended due to the severity of their [[side effects]] in growing [[children]] unless there are specific [[Indications and usage|indications]] such as [[Autoimmune diseases|autoimmune diseases.]]''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'' | |||
''<nowiki/>'' | |||
|} | |} | ||
Revision as of 21:07, 21 April 2020
|
Premature ventricular contraction Microchapters |
|
Differentiating Premature Ventricular Contraction from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Premature ventricular contraction other diagnostic studies On the Web |
|
FDA on Premature ventricular contraction other diagnostic studies |
|
CDC onPremature ventricular contraction other diagnostic studies |
|
Premature ventricular contraction other diagnostic studies in the news |
|
Blogs on Premature ventricular contraction other diagnostic studies |
|
to Hospitals Treating Premature ventricular contraction other diagnostic studies |
|
Risk calculators and risk factors for Premature ventricular contraction other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include:
- [Finding 1]
- [Finding 2]
- [Finding 3]
OR
Other diagnostic studies for [disease name] include:
- [Diagnostic study 1], which demonstrates:
- [Finding 1]
- [Finding 2]
- [Finding 3]
- [Diagnostic study 2], which demonstrates:
- [Finding 1]
- [Finding 2]
- [Finding 3]
2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]
Recommendations for Electrophysiological Study
| Class IIa |
| 1. In patients with ischemic cardiomyopathy, NICM, or adult congenital heart disease who have syncope or other VA symptoms and who do not meet indications for a primary prevention ICD, an electrophysiological study can be useful for assessing the risk of sustained VT (Level of Evidence: B-R).[2][3][4][5][6][7][8] |
| Class III |
| 1. Aspirin is not recommended in children due to the associated risk of Reye’s syndrome and hepatotoxicity.
2. Corticosteroids are not recommended due to the severity of their side effects in growing children unless there are specific indications such as autoimmune diseases.(Level of Evidence: C)
|
References
- ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; DiCarlo, Lorenzo; Gold, Michael R.; Greer, G. Stephen; Prystowsky, Eric N.; O'Toole, Michael F.; Tang, Anthony; Fisher, John D.; Coromilas, James; Talajic, Mario; Hafley, Gail (2000). "Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death". New England Journal of Medicine. 342 (26): 1937–1945. doi:10.1056/NEJM200006293422602. ISSN 0028-4793.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; Hafley, Gail E.; Wyse, D. George; Fisher, John D.; Lehmann, Michael H.; Pires, Luis A.; Gold, Michael R.; Packer, Douglas L.; Josephson, Mark E.; Prystowsky, Eric N.; Talajic, Mario R. (2002). "Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease". Circulation. 106 (19): 2466–2472. doi:10.1161/01.CIR.0000037224.15873.83. ISSN 0009-7322.
- ↑ Costantini, Otto; Hohnloser, Stefan H.; Kirk, Malcolm M.; Lerman, Bruce B.; Baker, James H.; Sethuraman, Barathi; Dettmer, Mary M.; Rosenbaum, David S. (2009). "The ABCD (Alternans Before Cardioverter Defibrillator) Trial". Journal of the American College of Cardiology. 53 (6): 471–479. doi:10.1016/j.jacc.2008.08.077. ISSN 0735-1097.
- ↑ Bourke, John P.; Richards, David A.B.; Ross, David L.; Wallace, Elizabeth M.; McGuire, Mark A.; Uther, John B. (1991). "Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening". Journal of the American College of Cardiology. 18 (3): 780–788. doi:10.1016/0735-1097(91)90802-G. ISSN 0735-1097.
- ↑ Schmitt, Claus; Barthel, Petra; Ndrepepa, Gjin; Schreieck, Jürgen; Plewan, Andreas; Schömig, A; Schmidt, Georg (2001). "Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers". Journal of the American College of Cardiology. 37 (7): 1901–1907. doi:10.1016/S0735-1097(01)01246-3. ISSN 0735-1097.
- ↑ Bailey, James J; Berson, Alan S; Handelsman, Harry; Hodges, Morrison (2001). "Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction". Journal of the American College of Cardiology. 38 (7): 1902–1911. doi:10.1016/S0735-1097(01)01667-9. ISSN 0735-1097.
- ↑ Hilfiker, Gabriela (2015). "Utility of electrophysiological studies to predict arrhythmic events". World Journal of Cardiology. 7 (6): 344. doi:10.4330/wjc.v7.i6.344. ISSN 1949-8462.